Platelet-Leukocyte Interactions in Inflammation and Atherothrombosis

ABSTRACT

Inflammatory processes at the vascular wall result in the development of atherosclerosis. Platelet interactions with leukocytes may play a key role in the initiation of inflammation. They trigger autocrine and paracrine activation processes, leading to leukocyte recruitment (in)to the vascular wall. This article highlights the molecular basis and the inflammatory pathways initiated by platelet-leukocyte interactions.

KEYWORDS

Platelets - inflammation - atherothrombosis - leukocytes - chemokines

REFERENCES

• 1 Ogura H, Kawasaki T, Tanaka H et al.. Activated platelets enhance microparticle formation and platelet-leukocyte interaction in severe trauma and sepsis.  J Trauma. 2001;  50 801-809
• 2 Mavrommatis A C, Theodoridis T, Orfanidou A et al.. Coagulation system and platelets are fully activated in uncomplicated sepsis.  Crit Care Med. 2000;  28 451-457
• 3 Ludwig R J, Schultz J E, Boehncke W H et al.. Activated, not resting, platelets increase leukocyte rolling in murine skin utilizing a distinct set of adhesion molecules.  J Invest Dermatol. 2004;  122 830-836
• 4 Berrettini M, Parise P, Constantini V et al.. Platelet activation in psoriasis.  Thromb Haemost. 1985;  53 195-197
• 5 Eibl N, Krugluger W, Streit G et al.. Improved metabolic control decreases platelet activation markers in patients with type-2 diabetes.  Eur J Clin Invest. 2004;  34 205-209
• 6 Shouzu A, Nomura S, Hayakawa T et al.. Effect of sarpogrelate hydrochloride on platelet-derived microparticles and various soluble adhesion molecules in diabetes mellitus.  Clin Appl Thromb Hemost. 2000;  6 139-143
• 7 Tschoepe D, Roesen P, Schwippert B et al.. Platelets in diabetes: the role in the hemostatic regulation in atherosclerosis.  Semin Thromb Hemost. 1993;  19 122-128
• 8 Ott I, Neumann F J, Gawaz M et al.. Increased neutrophil-platelet adhesion in patients with unstable angina.  Circulation. 1996;  94 1239-1246
• 9 May A E, Neumann F J, Gawaz M et al.. Reduction of monocyte-platelet interaction and monocyte activation in patients receiving antiplatelet therapy after coronary stent implantation.  Eur Heart J. 1997;  18 1913-1920
• 10 Neumann F J, Blasini R, Schmitt C et al.. Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction.  Circulation. 1998;  98 2695-2701
• 11 Massberg S, Brand K, Gruner S et al.. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation.  J Exp Med. 2002;  196 887-896
• 12 Huo Y, Schober A, Forlow S B et al.. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.  Nat Med. 2003;  9 61-67
• 13 Burger P C, Wagner D D. Platelet P-selectin facilitates atherosclerotic lesion development.  Blood. 2003;  101 2661-2666
• 14 Springer T A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm.  Cell. 1994;  76 301-314
• 15 Ni W, Egashira K, Kitamoto S et al.. New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice.  Circulation. 2001;  103 2096-2101
• 16 Gu L, Okada Y, Clinton S K et al.. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice.  Mol Cell. 1998;  2 275-281
• 17 Boring L, Gosling J, Cleary M et al.. Decreased lesion formation in CCR2 - / - mice reveals a role for chemokines in the initiation of atherosclerosis.  Nature. 1998;  394 894-897
• 18 da Costa Martins P A, van Gils J M, Mol A et al.. Platelet binding to monocytes increases the adhesive properties of monocytes by up-regulating the expression and functionality of beta 1 and beta 2 integrins.  J Leukoc Biol. 2006;  79 499-507
• 19 Neumann F J, Marx N, Gawaz M et al.. Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets.  Circulation. 1997;  95 2387-2394
• 20 Siegel-Axel D I, Gawaz M. Platelets and endothelial cells.  Semin Thromb Hemost. 2007;  33 128-135
• 21 Weber C. Platelets and chemokines in atherosclerosis: partners in crime.  Circ Res. 2005;  96 612-616
• 22 von Hundelshausen P, Weber K S, Huo Y et al.. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium.  Circulation. 2001;  103 1772-1777
• 23 Schober A, Manka D, von Hundelshausen P et al.. Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury.  Circulation. 2002;  106 1523-1529
• 24 Scheuerer B, Ernst M, Durrbaum-Landmann I et al.. The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages.  Blood. 2000;  95 1158-1166
• 25 Sachais B S, Kuo A, Nassar T et al.. Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic machinery, resulting in retention of low-density lipoprotein on the cell surface.  Blood. 2002;  99 3613-3622
• 26 Nassar T, Sachais B S, Akkawi S et al.. Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cells.  J Biol Chem. 2003;  278 6187-6193
• 27 Pitsilos S, Hunt J, Mohler E R et al.. Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters.  Thromb Haemost. 2003;  90 1112-1120
• 28 McEver R P. Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation.  Thromb Haemost. 2001;  86 746-756
• 29 Simon D I, Chen Z, Xu H et al.. Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18).  J Exp Med. 2000;  192 193-204
• 30 Santoso S, Sachs U J, Kroll H et al.. The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1.  J Exp Med. 2002;  196 679-691
• 31 Diacovo T G, de Fougerolles A R, Bainton D F et al.. A functional integrin ligand on the surface of platelets: intercellular adhesion molecule-2.  J Clin Invest. 1994;  94 1243-1251
• 32 Altieri D C, Bader R, Mannucci P M et al.. Oligospecificity of the cellular adhesion receptor Mac-1 encompasses an inducible recognition specificity for fibrinogen.  J Cell Biol. 1988;  107 1893-1900
• 33 Wright S D, Weitz J I, Huang A J et al.. Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen.  Proc Natl Acad Sci USA. 1988;  85 7734-7738
• 34 Chavakis T, Santoso S, Clemetson K J et al.. High molecular weight kininogen regulates platelet-leukocyte interactions by bridging Mac-1 and glycoprotein Ib.  J Biol Chem. 2003;  278 45375-45381
• 35 McEver R P, Cummings R D. Role of PSGL-1 binding to selectins in leukocyte recruitment.  J Clin Invest. 1997;  100 S97-S103
• 36 Weyrich A S, Elstad M R, McEver R P et al.. Activated platelets signal chemokine synthesis by human monocytes.  J Clin Invest. 1996;  97 1525-1534
• 37 Celi A, Pellegrini G, Lorenzet R et al.. P-selectin induces the expression of tissue factor on monocytes.  Proc Natl Acad Sci USA. 1994;  91 8767-8771
• 38 Weyrich A S, McIntyre T M, McEver R P et al.. Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion. Signal integration and NF-kappa B translocation.  J Clin Invest. 1995;  95 2297-2303
• 39 Mahoney T S, Weyrich A S, Dixon D A et al.. Cell adhesion regulates gene expression at translational checkpoints in human myeloid leukocytes.  Proc Natl Acad Sci USA. 2001;  98 10284-10289
• 40 May A E, Kanse S M, Lund L R et al.. Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo.  J Exp Med. 1998;  188 1029-1037
• 41 May A E, Schmidt R, Kanse S M et al.. Urokinase receptor surface expression regulates monocyte adhesion in acute myocardial infarction.  Blood. 2002;  100 3611-3617
• 42 Preissner K T, Kanse S M, May A E. Urokinase receptor: a molecular organizer in cellular communication.  Curr Opin Cell Biol. 2000;  12 621-628
• 43 Alderson M R, Armitage R J, Tough T W et al.. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40.  J Exp Med. 1993;  178 669-674
• 44 Galt S W, Lindemann S, Medd D et al.. Differential regulation of matrix metalloproteinase-9 by monocytes adherent to collagen and platelets.  Circ Res. 2001;  89 509-516
• 45 Fitzgerald D J, Roy L, Catella F et al.. Platelet activation in unstable coronary disease.  N Engl J Med. 1986;  315 983-989
• 46 Collins R, Baigent C, Sandercock P et al.. Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists' Collaboration.  BMJ. 1994;  309 1215-1217
• 47 Fox K A, Mehta S R, Peters R et al.. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable Angina to Prevent Recurrent Ischemic Events (CURE) Trial.  Circulation. 2004;  110 1202-1208
• 48 Sarma J, Laan C A, Alam S et al.. Increased platelet binding to circulating monocytes in acute coronary syndromes.  Circulation. 2002;  105 2166-2171
• 49 Furman M I, Barnard M R, Krueger L A et al.. Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction.  J Am Coll Cardiol. 2001;  38 1002-1006
• 50 Michelson A D, Barnard M R, Krueger L A et al.. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction.  Circulation. 2001;  104 1533-1537
• 51 Neumann F J, Zohlnhofer D, Fakhoury L et al.. Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction.  J Am Coll Cardiol. 1999;  34 1420-1426
• 52 Dole V S, Bergmeier W, Mitchell H A et al.. Activated platelets induce Weibel-Palade-body secretion and leukocyte rolling in vivo: role of P-selectin.  Blood. 2005;  106 2334-2339
• 53 Falati S, Liu Q, Gross P et al.. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin.  J Exp Med. 2003;  197 1585-1598
• 54 Falati S, Gross P, Merrill-Skoloff G et al.. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse.  Nat Med. 2002;  8 1175-1181